U.K. reclassifies liquid paracetamol
This article was originally published in The Tan Sheet
The Medicines and Healthcare products Regulatory Agency increases the maximum strength of liquid paracetamol, marketed as acetaminophen in the U.S., available for general sale from 2.5 percent to 5 percent for use by adults and children over 12 years of age. Liquid paracetamol preparations previously could only be offered in general sale - the equivalent of OTC in the U.S. - in 2.5 percent solutions and consumers would have to buy 5 percent preparations from a pharmacist, the U.K. agency announces Aug. 21
You may also be interested in...
American Injectables plans to build up its US-based manufacturing after securing a commitment for $10m of ‘Series A’ financing from New Rhein Healthcare Investors, which it will use to scale up production and launch several generic parenteral products.
A draft EU guideline explains how disease registries can be used to supplement evidence in the pre-authorization phase and provide infrastructure for post-authorization evidence generation.
Drug companies have their last chance to negotiate which documents and information Italy’s regulator, AIFA, will be entitled to request of them when they submit pricing and reimbursement applications.